First patients dosed in Telix Pharmaceutical's (ASX:TLX) Phase 3 US trial

Latest Company News - Finance News Network

English - January 24, 2021 23:55 - 48 seconds - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Beacon Lighting Group (ASX:BLX) subfund to acquire WA showroom

Next Episode: PointsBet (ASX:PBH) appoints Shaquille ONeal as Australian Brand Ambassador

25 Jan 2021 - Bio-tech company Telix Pharmaceuticals (ASX:TLX) Phase 3 clinical trial of its renal cancer diagnostic imaging product, Zircon has commenced in the US.